S&P 500   3,360.59 (-0.75%)
DOW   29,104.36 (-0.83%)
QQQ   233.68 (-1.39%)
AAPL   320.21 (-1.05%)
FB   214.41 (-1.42%)
MSFT   183.05 (-2.26%)
GOOGL   1,515.76 (-0.60%)
AMZN   2,139.70 (-1.41%)
CGC   22.34 (+2.62%)
NVDA   305.85 (-2.81%)
BABA   217.12 (-2.26%)
MU   58.61 (-2.30%)
GE   12.54 (-0.56%)
TSLA   875.77 (-4.54%)
AMD   57.12 (-3.02%)
T   38.42 (-0.05%)
F   8.02 (+0.25%)
BAC   34.74 (+0.06%)
DIS   139.54 (-1.25%)
GILD   66.43 (-1.37%)
S&P 500   3,360.59 (-0.75%)
DOW   29,104.36 (-0.83%)
QQQ   233.68 (-1.39%)
AAPL   320.21 (-1.05%)
FB   214.41 (-1.42%)
MSFT   183.05 (-2.26%)
GOOGL   1,515.76 (-0.60%)
AMZN   2,139.70 (-1.41%)
CGC   22.34 (+2.62%)
NVDA   305.85 (-2.81%)
BABA   217.12 (-2.26%)
MU   58.61 (-2.30%)
GE   12.54 (-0.56%)
TSLA   875.77 (-4.54%)
AMD   57.12 (-3.02%)
T   38.42 (-0.05%)
F   8.02 (+0.25%)
BAC   34.74 (+0.06%)
DIS   139.54 (-1.25%)
GILD   66.43 (-1.37%)
S&P 500   3,360.59 (-0.75%)
DOW   29,104.36 (-0.83%)
QQQ   233.68 (-1.39%)
AAPL   320.21 (-1.05%)
FB   214.41 (-1.42%)
MSFT   183.05 (-2.26%)
GOOGL   1,515.76 (-0.60%)
AMZN   2,139.70 (-1.41%)
CGC   22.34 (+2.62%)
NVDA   305.85 (-2.81%)
BABA   217.12 (-2.26%)
MU   58.61 (-2.30%)
GE   12.54 (-0.56%)
TSLA   875.77 (-4.54%)
AMD   57.12 (-3.02%)
T   38.42 (-0.05%)
F   8.02 (+0.25%)
BAC   34.74 (+0.06%)
DIS   139.54 (-1.25%)
GILD   66.43 (-1.37%)
S&P 500   3,360.59 (-0.75%)
DOW   29,104.36 (-0.83%)
QQQ   233.68 (-1.39%)
AAPL   320.21 (-1.05%)
FB   214.41 (-1.42%)
MSFT   183.05 (-2.26%)
GOOGL   1,515.76 (-0.60%)
AMZN   2,139.70 (-1.41%)
CGC   22.34 (+2.62%)
NVDA   305.85 (-2.81%)
BABA   217.12 (-2.26%)
MU   58.61 (-2.30%)
GE   12.54 (-0.56%)
TSLA   875.77 (-4.54%)
AMD   57.12 (-3.02%)
T   38.42 (-0.05%)
F   8.02 (+0.25%)
BAC   34.74 (+0.06%)
DIS   139.54 (-1.25%)
GILD   66.43 (-1.37%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 OmerosTherapeuticsMDDiaMedica TherapeuticsRetrophinEmisphere Technologies
SymbolNASDAQ:OMERNASDAQ:TXMDOTCMKTS:DMCAFNASDAQ:RTRXOTCMKTS:EMIS
Price Information
Current Price$13.24$2.10N/A$16.57$7.80
52 Week RangeBuyBuyN/ABuyN/A
Analyst Ratings
Consensus RecommendationBuyBuyN/ABuyN/A
Consensus Price Target$25.75$9.11N/A$29.71N/A
% Upside from Price Target94.49% upside333.86% upsideN/A79.33% upsideN/A
Trade Information
Market Cap$665.66 million$656.25 million$730.70 million$710.46 million$659.56 million
Beta2.641.65-0.020.891.99
Average Volume309,1552,626,263131,151237,33450,855
Sales & Book Value
Annual Revenue$29.87 million$16.10 millionN/A$164.25 millionN/A
Price / Sales22.0535.37N/A4.33N/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value($2.04) per share$0.41 per shareN/A$7.72 per shareN/A
Price / Book-6.495.12N/A2.15N/A
Profitability
Net Income$-126,760,000.00$-132,620,000.00$-2,220,000.00$-102,680,000.00N/A
EPS($2.22)($0.59)N/A($2.54)N/A
Trailing P/E RatioN/AN/A0.00N/A0.00
Forward P/E RatioN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-78.48%-427.70%N/A-71.70%N/A
Return on Equity (ROE)N/A-430.28%N/A-43.88%N/A
Return on Assets (ROA)-71.81%-70.11%N/A-18.74%N/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A24.29%N/A0.82%N/A
Current Ratio1.36%2.85%N/A5.00%N/A
Quick Ratio1.34%2.69%N/A4.94%N/A
Ownership Information
Institutional Ownership Percentage50.97%62.68%N/AN/A0.03%
Insider Ownership Percentage12.80%18.91%N/A4.32%72.90%
Miscellaneous
Employees236241N/A2146
Shares Outstanding49.75 million271.18 million157.14 million42.95 million84.02 million
Next Earnings Date3/6/2020 (Estimated)2/20/2020 (Confirmed)N/A2/24/2020 (Confirmed)N/A
OptionableOptionableOptionableNot OptionableOptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel